Blanver is committed to continuously improving its products and operations.

Major initiatives include the following:

To establish methods and systems to reduce costs in production, packaging, transportation, material handling for all products, including the development and construction of a unique and more efficient production equipment.
Training for all staff to enhance their professional skills.
Streamlining the organizational structure to expedite decision making.
Conduct internal audits of all departments, resulting in preventive and corrective actions to eliminate repetitive errors.
Ensuring the quality of our products using strict physical controls, chemical and microbiological contaminants.
Follow strictly to Good Manufacturing Practices and other international standards, as established by the FDA and other regulatory agencies.
Provide technical assistance, working closely with our customers and partners.

Rigorous quality control methods adopted by Blanver ensure that our products fully comply with international standards of quality of pharmaceutical raw materials and foods.

Our products meet all specification requirements according to international pharmacopoeias such as the United States Pharmacopoeia / National Formulary (USP / NF), European Pharmacopoeia, Japanese Pharmacopoeia and others.

For each lot of our finished products, in addition to physical, chemical and microbiological tests required by the above mentioned Pharmacopoeias, we also conduct application tests as a final inspection of each sold lot, ensuring an exceptional uniformity between lots.

As an additional safeguard, and for possible future studies, Blanver retains a sample of every lot for five years.